Published in Virology on November 01, 1979
Comparison of Epstein-Barr virus strains of different origin by analysis of the viral DNAs. J Virol (1980) 3.00
The Epstein-Barr virus (EBV) BZLF1 immediate-early gene product differentially affects latent versus productive EBV promoters. J Virol (1989) 2.65
Unique spectrum of activity of 9-[(1,3-dihydroxy-2-propoxy)methyl]-guanine against herpesviruses in vitro and its mode of action against herpes simplex virus type 1. Proc Natl Acad Sci U S A (1983) 2.54
Immune regulation in Epstein-Barr virus-associated diseases. Microbiol Rev (1995) 1.90
Prolonged inhibitory effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine against replication of Epstein-Barr virus. J Virol (1984) 1.88
The Epstein-Barr virus immediate-early gene product, BMLF1, acts in trans by a posttranscriptional mechanism which is reporter gene dependent. J Virol (1989) 1.86
BFRF1 of Epstein-Barr virus is essential for efficient primary viral envelopment and egress. J Virol (2005) 1.59
Epstein-Barr virus polypeptides: effect of inhibition of viral DNA replication on their synthesis. J Virol (1981) 1.48
Polypeptide synthesis and phosphorylation in Epstein-Barr virus-infected cells. J Virol (1980) 1.43
Regulation of the Epstein-Barr virus DNA polymerase gene. J Virol (1992) 1.31
The BFRF1 gene of Epstein-Barr virus encodes a novel protein. J Virol (2000) 1.20
Qualitative and quantitative analyses of Epstein-Barr virus early antigen diffuse component by western blotting enzyme-linked immunosorbent assay with a monoclonal antibody. J Virol (1985) 1.20
Either ZEB1 or ZEB2/SIP1 can play a central role in regulating the Epstein-Barr virus latent-lytic switch in a cell-type-specific manner. J Virol (2010) 1.17
Comparative efficacy and selectivity of some nucleoside analogs against Epstein-Barr virus. Antimicrob Agents Chemother (1985) 1.07
Identification and characterization of a DNase induced by Epstein-Barr virus. J Virol (1982) 1.03
Metabolic activation of 9([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine in human lymphoblastoid cell lines infected with Epstein-Barr virus. J Virol (1986) 1.00
Two strains of Epstein-Barr virus (B95-8 and a P3HR-1 subclone) that lack defective genomes induce early antigen and cause abortive infection of Raji cells. J Virol (1987) 0.99
Role of the TSG101 gene in Epstein-Barr virus late gene transcription. J Virol (2006) 0.98
Herpesvirus sylvilagus I. Polypeptides of virions and nucleocapsids. J Virol (1982) 0.97
Activation of latent Epstein-Barr virus genomes: selective stimulation of synthesis of chromosomal proteins by a tumor promoter. J Virol (1983) 0.95
Comparison of two bromovinyl nucleoside analogs, 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil and E-5-(2-bromovinyl)-2'-deoxyuridine, with acyclovir in inhibition of Epstein-Barr virus replication. Antimicrob Agents Chemother (1988) 0.91
Molecular events associated with epithelial to mesenchymal transition of nasopharyngeal carcinoma cells in the absence of Epstein-Barr virus genome. J Biomed Sci (2009) 0.89
Filamentous structures associated with Epstein-Barr virus-infected cells. J Virol (1982) 0.78
Tumor promoters alter the temporal program of adenovirus replication in human cells. Mol Cell Biol (1981) 0.77
Sequential detection of different antigens induced by Epstein-Barr virus and herpes simplex virus in the same Western blot by using dual antibody probes. J Virol (1986) 0.77
Enchancement of the infectivity of simian virus 40 deoxyribonucleic acid with diethylaminoethyl-dextran. J Natl Cancer Inst (1968) 21.44
Detection of Epstein-Barr viral genome in nonproductive cells. Nat New Biol (1971) 7.91
Evolutionary relationships among diverse bacteriophages and prophages: all the world's a phage. Proc Natl Acad Sci U S A (1999) 7.05
Television viewing time and mortality: the Australian Diabetes, Obesity and Lifestyle Study (AusDiab). Circulation (2010) 7.03
Homology between Epstein-Barr virus DNA and viral DNA from Burkitt's lymphoma and nasopharyngeal carcinoma determined by DNA-DNA reassociation kinetics. Nature (1973) 6.68
In vitro site-specific integration of bacteriophage DNA catalyzed by a recombinase of the resolvase/invertase family. Proc Natl Acad Sci U S A (1998) 5.04
Structural polypeptides of simian virus 40. J Virol (1971) 4.83
Separation of Epstein-Barr virus DNA from large chromosomal DNA in non-virus-producing cells. Nat New Biol (1972) 4.66
Epstein-Barr virus replication in oropharyngeal epithelial cells. N Engl J Med (1984) 4.47
Human cytomegalovirus. I. Purification and characterization of viral DNA. J Virol (1973) 4.43
Extrachromosomal DNA transformation of Caenorhabditis elegans. Mol Cell Biol (1985) 4.37
Analysis of simian virus 40 DNA with the restriction enzyme of Haemophilus aegyptius, endonuclease Z. J Virol (1973) 3.98
Immediate-early gene region of human cytomegalovirus trans-activates the promoter of human immunodeficiency virus. Proc Natl Acad Sci U S A (1987) 3.82
Protein degradation in E. coli: the lon mutation and bacteriophage lambda N and cII protein stability. Cell (1981) 3.58
Insulin-like growth factor II receptor as a multifunctional binding protein. Nature (1987) 3.52
Waist circumference, waist-hip ratio and body mass index and their correlation with cardiovascular disease risk factors in Australian adults. J Intern Med (2003) 3.39
Effect of the Gulf War on infant and child mortality in Iraq. N Engl J Med (1992) 3.03
Associations of TV viewing and physical activity with the metabolic syndrome in Australian adults. Diabetologia (2005) 3.02
Peripheral nerve tumors with rhabdomyosarcomatous differentiation (malignant "Triton" tumors). Cancer (1973) 2.97
Factors influencing the enhancement of the infectivity of poliovirus ribonucleic acid by diethylaminoethyl-dextran. J Virol (1967) 2.95
Analysis of osm-6, a gene that affects sensory cilium structure and sensory neuron function in Caenorhabditis elegans. Genetics (1998) 2.83
Replication of Epstein-Barr virus in human epithelial cells infected in vitro. Nature (1984) 2.81
Control of directionality in the site-specific recombination system of the Streptomyces phage phiC31. Mol Microbiol (2000) 2.78
IRF-7, a new interferon regulatory factor associated with Epstein-Barr virus latency. Mol Cell Biol (1997) 2.70
EBNA-2 transactivates a lymphoid-specific enhancer in the BamHI C promoter of Epstein-Barr virus. J Virol (1991) 2.70
Effect of acyclovir [9-(2-hydroxyethoxymethyl)guanine] on Epstein-Barr virus DNA replication. J Virol (1980) 2.69
The Epstein-Barr virus (EBV) BZLF1 immediate-early gene product differentially affects latent versus productive EBV promoters. J Virol (1989) 2.65
Reassociation kinetics for Epstein-Barr virus DNA: nonhomology to mammalian DNA and homology of viral DNA in various diseases. J Virol (1973) 2.57
Unique spectrum of activity of 9-[(1,3-dihydroxy-2-propoxy)methyl]-guanine against herpesviruses in vitro and its mode of action against herpes simplex virus type 1. Proc Natl Acad Sci U S A (1983) 2.54
Detection of human cytomegalovirus and analysis of strain variation. Yale J Biol Med (1976) 2.53
Direct evidence of attempted beta cell regeneration in an 89-year-old patient with recent-onset type 1 diabetes. Diabetologia (2006) 2.53
The Evaluation of Screening and Early Detection Strategies for Type 2 Diabetes and Impaired Glucose Tolerance (DETECT-2) update of the Finnish diabetes risk score for prediction of incident type 2 diabetes. Diabetologia (2010) 2.33
Resumption of virus production after human immunodeficiency virus infection of T lymphocytes in the presence of azidothymidine. J Virol (1987) 2.33
Infectious poliovirus RNA: a sensitive method of assay. Virology (1965) 2.28
Enhancement of infectivity of poliovirus RNA with diethylaminoethyl-dextran (DEAE-D). Arch Gesamte Virusforsch (1965) 2.25
Acyclovir inhibition of Epstein-Barr virus replication. Proc Natl Acad Sci U S A (1980) 2.23
Structure and function of the polypeptides in simian virus 40. I. Existence of subviral deoxynucleoprotein complexes. J Virol (1972) 2.16
Accuracy of the diagnosis of hypertensive nephrosclerosis in African Americans: a report from the African American Study of Kidney Disease (AASK) Trial. AASK Pilot Study Investigators. Kidney Int (1997) 2.11
Prostaglandin: release from the rat phrenic nerve--diaphragm preparation. Science (1965) 2.08
Efflux of prostaglandin from adrenal glands stimulated with acetylcholine. Nature (1966) 2.07
DNA of Epstein-Barr virus detected in tissue of Burkitt's lymphoma and nasopharyngeal carcinoma. Proc Natl Acad Sci U S A (1973) 2.02
Human cytomegalovirus. II. Lack of relatedness to DNA of herpes simples I and II, Epstein-Barr virus, and nonhuman strains of cytomegalovirus. J Virol (1974) 1.99
Spontaneous and evoked release of prostaglandins from cerebral cortex of anesthetized cats. Am J Physiol (1966) 1.93
Release of prostaglandin from rat epididymal fat pad on nervous and hormonal stimulation. J Biol Chem (1968) 1.93
Structural determinants for transcriptional activation by cAMP-responsive DNA elements. J Biol Chem (1988) 1.93
Expression of the Epstein-Barr virus BamHI A fragment in nasopharyngeal carcinoma: evidence for a viral protein expressed in vivo. J Virol (1991) 1.91
Nucleosomal structure of Epstein-Barr virus DNA in transformed cell lines. J Virol (1979) 1.91
The C. elegans gene lin-44, which controls the polarity of certain asymmetric cell divisions, encodes a Wnt protein and acts cell nonautonomously. Cell (1995) 1.89
Prolonged inhibitory effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine against replication of Epstein-Barr virus. J Virol (1984) 1.88
Analysis of cytomegalovirus genomes with restriction endonucleases Hin D III and EcoR-1. J Virol (1976) 1.87
Correlation of trabecular bone structure with age, bone mineral density, and osteoporotic status: in vivo studies in the distal radius using high resolution magnetic resonance imaging. J Bone Miner Res (1997) 1.86
The Epstein-Barr virus immediate-early gene product, BMLF1, acts in trans by a posttranscriptional mechanism which is reporter gene dependent. J Virol (1989) 1.86
Continuous relationships between non-diabetic hyperglycaemia and both cardiovascular disease and all-cause mortality: the Australian Diabetes, Obesity, and Lifestyle (AusDiab) study. Diabetologia (2009) 1.85
Validity of self-reported cardiovascular disease events in comparison to medical record adjudication and a statewide hospital morbidity database: the AusDiab study. Intern Med J (2009) 1.81
Biological significance of the prostaglandins. Recent Prog Horm Res (1970) 1.81
IRF7: activation, regulation, modification and function. Genes Immun (2011) 1.80
Independent and opposite associations of waist and hip circumferences with diabetes, hypertension and dyslipidemia: the AusDiab Study. Int J Obes Relat Metab Disord (2004) 1.78
Report of an IEEE task force--an IEEE opinion on research needs for biomedical engineering systems. IEEE Trans Biomed Eng (1986) 1.77
The uptake of SV40 DNA by nonpermissive cells in the presence of DEAE-dextran. Biochim Biophys Acta (1971) 1.76
The expression of matrix metalloproteinase 9 is enhanced by Epstein-Barr virus latent membrane protein 1. Proc Natl Acad Sci U S A (1998) 1.75
Lifetime risk and projected population prevalence of diabetes. Diabetologia (2008) 1.73
Absence of Epstein-Barr viral DNA in Amercian Burkitt's lymphoma. N Engl J Med (1973) 1.72
Cytotoxicity of sesquiterpene lactones. Cancer Res (1971) 1.71
Replication of viral deoxyribonucleic acid and breakdown of cellular deoxyribonucleic acid in Epstein-Barr virus infection. J Virol (1972) 1.70
eat-5 and unc-7 represent a multigene family in Caenorhabditis elegans involved in cell-cell coupling. J Cell Biol (1996) 1.70
Minimum speed limit for ocean ridge magmatism from 210Pb-226Ra-230Th disequilibria. Nature (2005) 1.69
The arginine repressor is essential for plasmid-stabilizing site-specific recombination at the ColE1 cer locus. EMBO J (1988) 1.67
Induction of cyclooxygenase-2 by Epstein-Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells. Proc Natl Acad Sci U S A (2001) 1.63
A microtiter plate technique for the agglutination typing of Diplococcus pneumoniae. J Infect Dis (1970) 1.62
A second site for Epstein-Barr virus shedding: the uterine cervix. Lancet (1986) 1.61
Replication of EBV in epithelial cells during infectious mononucleosis. Nature (1977) 1.61
Foot complications in Type 2 diabetes: an Australian population-based study. Diabet Med (2003) 1.58
Induction of Epstein-Barr virus-associated DNA polymerase by 12-O-tetradecanoylphorbol-13-acetate. Purification and characterization. J Biol Chem (1980) 1.57
Epstein-Barr virus transcription in nasopharyngeal carcinoma. J Virol (1983) 1.57
Oral poliovirus vaccination in newborn African infants. The inhibitory effect of breast feeding. Am J Dis Child (1966) 1.56
Structural proteins of simian virus 40. I. Histone characteristics of low-molecular-weight polypeptides. J Virol (1975) 1.56
The rubrospinal and central tegmental tracts in man. Brain (1982) 1.55
Novel acyclic adenosine analogs inhibit Epstein-Barr virus replication. Antimicrob Agents Chemother (1987) 1.55
Epstein-Barr virus DNA synthesized in superinfected Raji cells. Virology (1977) 1.55
Stress-inducible transcription factor CHOP/gadd153 induces apoptosis in mammalian cells via p38 kinase-dependent and -independent mechanisms. Exp Cell Res (2001) 1.54
Factors associated with inadequate blood pressure control in hypertensive hemodialysis patients. Am J Kidney Dis (1999) 1.54
Transdermal scopolamine in the prevention of motion sickness at sea. Clin Pharmacol Ther (1981) 1.53
Use of vitamin-mineral supplements by AFDC children. Public Health Rep (1985) 1.53
The clinical spectrum of renal cholesterol embolization. Am J Med (1981) 1.51
Morphogenetic genes C and Nu3 overlap in bacteriophage lambda. Nature (1980) 1.49
Epstein-Barr virus polypeptides: effect of inhibition of viral DNA replication on their synthesis. J Virol (1981) 1.48
Autologous human B and T lymphoblastoid cell lines. Nature (1974) 1.48
Structure and function of the polypeptides in simian virus 40. II. Transcription of subviral deoxynucleoprotein complexes in vitro. J Virol (1972) 1.47
Changes in the incisor teeth of albino rats with vitamin a deficiency and the effects of replacement therapy. Am J Pathol (1941) 1.46
Epstein-Barr virus: culprit or consort? N Engl J Med (1992) 1.46
Cellular basis for susceptibility to mouse cytomegalovirus: evidence from tracheal organ culture. J Gen Virol (1979) 1.46
Chronic renal insufficiency: a diagnostic and therapeutic approach. Arch Intern Med (1998) 1.45
Functional mutation in the promoter region of thrombomodulin gene in relation to carotid atherosclerosis. Atherosclerosis (2001) 1.45